BTIG Maintains a Buy on Apogee Therapeutics (APGE)

Apogee Therapeutics Inc. (NASDAQ:APGE) is one of the best healthcare stocks with the highest upside. BTIG analyst Julian Harrison maintained a Buy rating on Apogee Therapeutics Inc. (NASDAQ:APGE) on October 10, keeping the associated price target at $115. 10 Best Biotech Stocks To Buy Under $20 The analyst based the optimistic rating on the company’s promising clinical developments, along with the potential of its APG777, especially to treat asthma, atopic dermatitis, and eosinophilic esophagitis. Accor ...